Rheumatic heart disease in Africa: Is there a role for genetic studies?

Cardiovascular Journal of Africa

Volumn 26, Issue 2, 2015, Pages S21-S26

  Mocumbi, Ana Olga ^a  

^a INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

Genetic susceptibility; Rheumatic fever; Rheumatic heart disease

Indexed keywords

BENZATHINE PENICILLIN; C REACTIVE PROTEIN; CROSS REACTING ANTIBODY; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AFRICA; ALLELE; ARTICLE; CROWDING (AREA); ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GOLD STANDARD; GRANULOMATOUS INFLAMMATION; GROUP A STREPTOCOCCAL INFECTION; HAPLOTYPE; HEART AUSCULTATION; HEREDITY; HISTOCOMPATIBILITY; HUMAN; MOLECULAR MIMICRY; PATHOGENESIS; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW (TOPIC); URBAN AREA; DISEASE COURSE; GENOME-WIDE ASSOCIATION STUDY; RISK FACTOR; SECONDARY PREVENTION;

AFRICA; DISEASE PROGRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK FACTORS; SECONDARY PREVENTION;

EID: 84930012495     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2015-037     Document Type: Article

References (49)

1. Okello E, Beaton A, Mondo CK, Kruszka P, Kiwanuka N, Odoi-Adome R, et al. Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study. BMC Cardiovasc Disord 2014; 14: 28. doi: 10.1186/1471-2261-14-28
2. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011; 3: 67-84. doi: 10.2147/CLEP.S12977.
3. Rothenbühler M, O'Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health 2014; 2(12): e717-726. doi: 10.1016/S2214-109X(14)70310-9.
4. Shulman ST, Stollermwan R, Beall B, Dale JB, Tanz RR. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis 2006; 42: 441-447.
5. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM; World Heart Federation. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol 2013; 10(5): 284-292. doi: 10.1038/nrcardio.2013.34.
6. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clinic Proc 2010; 85(5): 483-500. doi: 10.4065/mcp.2009.0706.
7. WHO Regional Committee for Africa. Cardiovascular diseases in the African region: current situation and perspectives - report of the regional director 2005. http://www.afro.who.int/rc55/documents/afr-rc55-12-cardiovascular.pdf
8. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5: 685-694
9. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357: 470-476.
10. Rossi E, Felici AR, Banteyrga L. Subclinical rheumatic heart disease in an Eritrean high-school population, detected by echocardiography. J Heart Valve Dis 2014; 23(2): 235-239.
11. Beaton A, Okello E, Aliku T, Lubega S, Lwabi P, Mondo C, et al. Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection. Pediatr Cardiol 2014; 35(7): 1259-1267. doi: 10.1007/s00246-014-0925-3.
12. Carapetis J. Rheumatic heart disease in developing countries. N Engl J Med 2007; 357(5): 439-441.
13. Parks T, Smeesters PR, Steer AC. Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis 2012; 25(2): 145-153. doi: 10.1097/QCO.0b013e3283511d27.
14. Viswanathan V. Acute rheumatic fever. Indian J Rheumatol 2012; 7(1): 36-43.
15. Delunardo F, Scalzi V, Capozzi A, Camerini S, Misasi R, Pierdominici M, et al. Streptococcal-vimentin cross-reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease. Clin Exp Immunol 2013; 173(3): 419-429. doi: 10.1111/cei.12135.
16. Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 2010; 30: 17-23.
17. Guilherme L, Kalil J. Rheumatic heart disease: molecules involved in valve tissue inflammation leading to the autoimmune process and anti-S. pyogenes vaccine. Front Immunol 2013; 4: 352. doi: 10.3389/fimmu.2013.00352.
18. Guilherme L, Kalil J. Rheumatic fever - from innate to acquire immune response. Ann NY Acad Sci 2007; 1107: 426-433
19. Cunningham MW. Molecular mimicry, autoimmunity and infection in the pathogenesis of rheumatic fever. Int Congr Ser 2006; 1289: 14-19.
20. Love GL, Restrepo C. Aschoff bodies of rheumatic carditis are granulomatous lesions of histiocytic origin. Mod Pathol 1988; 1(4): 256-261.
21. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 8th edn. Philadelphia: Elsevier Inc, 2010.
22. McPhee SJ, Papadakis MA. 2011 Current Medical Diagnosis & Treatment. 50th edn. United States: McGraw-Hill, 2011.
23. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012; 379: 953-964.
24. Júnior AR, Oliveira CD, Fontes MJ, Lasmar LM, Camargos EP. Diagnosis of streptococcal pharyngotonsillitis in children and adolescents: clinical picture limitations. Rev Paul Pediatr 2014; 32(4): 285-291. doi: 10.1016/j.rpped.2014.04.001. Portuguese.
25. Leung AK, Newman R, Kumar A, Davies HD. Rapid antigen detection testing in diagnosing group A β-hemolytic streptococcal pharyngitis. Expert Rev Mol Diagn 2006; 6(5): 761-766.
26. Parks T, Kado J, Colquhoun S, Carapetis J, Steer A. Underdiagnosis of acute rheumatic fever in primary care settings in a developing country. Trop Med Int Health 2009; 14: 1407-1413. doi: 10.1111/j.1365-3156.2009.02385.x
27. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 2010; 31(6): 719-727. doi: 10.1093/eurheartj/ehp530. Epub 2009 Dec 7.
28. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012; 379: 953-964.
29. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease - an evidence-based guideline. Nat Rev Cardiol 2012; 9(5): 297-309.
30. Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2014. pii: ehu449.
31. Essop MR, Nkomo VT. Rheumatic and Non-rheumatic valvular heart disease: epidemiology, management and prevention in Africa. Circulation 2005; 112: 3584-3591.
32. Tadele H, Mekonnen W, Tefera E. Rheumatic mitral stenosis in children: more accelerated course in sub-Saharan patients. BMC Cardiovasc Dis 2013; 13: 95. doi: 10.1186/1471-2261-13-95.
33. Currie BJ. Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever? Pediatrics 1996; 97(6 Pt 2): 989-991.
34. Guéant JL, Romano A, Cornejo-Garcia JA, Oussalah A, Chery C, Blanca-López N, et al. HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping. J Allergy Clin Immunol 2014. pii: S0091-6749(14)01051-3. doi: 10.1016/j.jaci.2014.07.047
35. Cunningham MW. Streptococcus and rheumatic fever. Curr Opin Rheumatol 2012; 24: 408-416.
36. Gourley M, Miller FW. Mechanisms of disease: environmental factors in the pathogenesis of rheumatic disease. Nat Clin Pract Rheum 2007; 3: 172-180.
37. Azevedo PM, Pereira RR, Guilherme L. Understanding rheumatic fever. Rheumatol Int 2012; 32(5): 1113-1120. doi: 10.1007/s00296-011-2152-z.
38. Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM. Genetic susceptibility to acute rheumatic fever: a systematic review and metaanalysis of twin studies. PLoS One 2011; 6(9): e25326. doi: 10.1371/journal.pone.0025326. Epub 2011 Sep 30.
39. Guilherme L, Köhler K F, Postol E, Kalil J. Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Card 2011; 4: 13-21.
40. Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. Some of the people, some of the time: Susceptibility to acute rheumatic fever. Circulation 2009; 119: 742-753.
41. Gupta U, Mir SS, Chauhan T, Garg N, Agarwal SK, Pande S, et al. Influence of protein tyrosine phosphatase gene (PTPN22) polymorphisms on rheumatic heart disease susceptibility in North Indian population. Tissue Antigens 2014; 84(5): 492-496.
42. Gupta U, Mir SS, Srivastava A, Garg N, Agarwal SK, Pande S, Mittal B. Signal transducers and activators of transcription (STATs) gene polymorphisms related with susceptibility to rheumatic heart disease in north Indian population. Immunol Lett 2014; 161(1): 100-105.
43. Gupta U, Mishra A, Rathore SS, Agarwal SK, Pande S, Garg N, Mittal B. Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease in Indian population and meta-analysis. Mol Cell Biochem 2013; 382(1-2): 75-82.
44. Mohamed AA, Rashed LA, Shaker SM, Ammar RI. Association of tumor necrosis factor-alpha polymorphisms with susceptibility and clinical outcomes of rheumatic heart disease. Saudi Med J 2010; 31(6): 644-649.
45. Rehman S, Akhtar N, Ahmad W, Ayub Q, Mehdi SQ, Mohyuddin A. Human leukocyte antigen (HLA) class II association with rheumatic heart disease in Pakistan. J Heart Valve Dis 2007; 16(3): 300-304.
46. Chou HT, Chen CH, Tsai CH, Tsai FJ. Association between transforming growth factor-beta 1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 2004; 148(1): 181-186.
47. Kamal H, Hussein G, Hassoba H, Mosaad N, Gad A, Ismail M. Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt. Acta Cardiol 2010; 65(2): 177-183.
48. Zhu L, Zou LJ, Hua R, Li B. Association of single-nucleotide polymorphisms in toll-like receptor 5 gene with rheumatic heart disease in Chinese Han population. Int J Cardiol 2010; 145(1): 129-130. doi: 10.1016/j.ijcard.2009.06.046. Epub 2009 Jul 17.
49. Aksoy R, Duman T, Keskin O, Düzgün N. No association of PTPN22 R620W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Mol Biol Rep 2011; 38(8): 5393-5396.